Methylprednisolone During the Switch Between Natalizumab and Fingolimod

Clinical trial NCT02769689 · UNKNOWN

Trial details

NCT number: NCT02769689
Sponsor: University Hospital, Clermont-Ferrand
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2019-06-12
Primary completion: 2024-06-20
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.